The American Psychiatric Association (APA) has updated its Privacy Policy and Terms of Use, including with new information specifically addressed to individuals in the European Economic Area. As described in the Privacy Policy and Terms of Use, this website utilizes cookies, including for the purpose of offering an optimal online experience and services tailored to your preferences.

Please read the entire Privacy Policy and Terms of Use. By closing this message, browsing this website, continuing the navigation, or otherwise continuing to use the APA's websites, you confirm that you understand and accept the terms of the Privacy Policy and Terms of Use, including the utilization of cookies.

×
Published Online:https://doi.org/10.1176/ps.39.5.501

In these two columns, we have briefly reviewed the research on the effects on memory of lithium, anticonvulsants, anticholinergics, neuroleptics, antidepressants, beta blockers, and benzodiazepines. Evidence suggests that all classes of psychotropic medication may have some deleterious effect on memory. However, the clinician must weigh the risk of memory loss due to psychotropic drugs against the risk that certain emotional illnesses, such as depression and severe anxiety, may themselves impair memory function if not treated.

Clinically significant effects on memory are most often seen when using drugs or combinations of drugs with high anticholinergic activity and when using short-acting benzodiazepines. Clinical evidence and some research suggest that geriatric patients are more sensitive to the potential memory impairment caused by psychotropic drugs, but more research data are needed.

Access content

To read the fulltext, please use one of the options below to sign in or purchase access.